JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · IE
$208.43
−0.86%Margins
Gross margin
84.7%
EBITDA margin
35.6%
EBIT margin
31.1%
Net margin
20.4%
FCF margin
33.5%
19.6%
Return on equity
8.5%
Return on assets
15.5%
Return on invested capital
0.40x
Asset turnover
$1.7B
Cash from operations
$34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026